211 related articles for article (PubMed ID: 25255029)
1. Prediction of multi-target networks of neuroprotective compounds with entropy indices and synthesis, assay, and theoretical study of new asymmetric 1,2-rasagiline carbamates.
Romero Durán FJ; Alonso N; Caamaño O; García-Mera X; Yañez M; Prado-Prado FJ; González-Díaz H
Int J Mol Sci; 2014 Sep; 15(9):17035-64. PubMed ID: 25255029
[TBL] [Abstract][Full Text] [Related]
2. TOPS-MODE model of multiplexing neuroprotective effects of drugs and experimental-theoretic study of new 1,3-rasagiline derivatives potentially useful in neurodegenerative diseases.
Luan F; Cordeiro MN; Alonso N; García-Mera X; Caamaño O; Romero-Duran FJ; Yañez M; González-Díaz H
Bioorg Med Chem; 2013 Apr; 21(7):1870-9. PubMed ID: 23415089
[TBL] [Abstract][Full Text] [Related]
3. Model for high-throughput screening of multitarget drugs in chemical neurosciences: synthesis, assay, and theoretic study of rasagiline carbamates.
Alonso N; Caamaño O; Romero-Duran FJ; Luan F; D S Cordeiro MN; Yañez M; González-Díaz H; García-Mera X
ACS Chem Neurosci; 2013 Oct; 4(10):1393-403. PubMed ID: 23855599
[TBL] [Abstract][Full Text] [Related]
4. Brain-inspired cheminformatics of drug-target brain interactome, synthesis, and assay of TVP1022 derivatives.
Romero-Durán FJ; Alonso N; Yañez M; Caamaño O; García-Mera X; González-Díaz H
Neuropharmacology; 2016 Apr; 103():270-8. PubMed ID: 26721628
[TBL] [Abstract][Full Text] [Related]
5. New Markov-Shannon Entropy models to assess connectivity quality in complex networks: from molecular to cellular pathway, Parasite-Host, Neural, Industry, and Legal-Social networks.
Riera-Fernández P; Munteanu CR; Escobar M; Prado-Prado F; Martín-Romalde R; Pereira D; Villalba K; Duardo-Sánchez A; González-Díaz H
J Theor Biol; 2012 Jan; 293():174-88. PubMed ID: 22037044
[TBL] [Abstract][Full Text] [Related]
6. 3D MI-DRAGON: new model for the reconstruction of US FDA drug- target network and theoretical-experimental studies of inhibitors of rasagiline derivatives for AChE.
Prado-Prado F; García-Mera X; Escobar M; Alonso N; Caamaño O; Yañez M; González-Díaz H
Curr Top Med Chem; 2012; 12(16):1843-65. PubMed ID: 23030618
[TBL] [Abstract][Full Text] [Related]
7. Using entropy of drug and protein graphs to predict FDA drug-target network: theoretic-experimental study of MAO inhibitors and hemoglobin peptides from Fasciola hepatica.
Prado-Prado F; García-Mera X; Abeijón P; Alonso N; Caamaño O; Yáñez M; Gárate T; Mezo M; González-Warleta M; Muiño L; Ubeira FM; González-Díaz H
Eur J Med Chem; 2011 Apr; 46(4):1074-94. PubMed ID: 21315497
[TBL] [Abstract][Full Text] [Related]
8. Multi-Target Mining of Alzheimer Disease Proteome with Hansch's QSBR-Perturbation Theory and Experimental-Theoretic Study of New Thiophene Isosters of Rasagiline.
Abeijon P; Garcia-Mera X; Caamano O; Yanez M; Lopez-Castro E; Romero-Duran FJ; Gonzalez-Diaz H
Curr Drug Targets; 2017; 18(5):511-521. PubMed ID: 26521774
[TBL] [Abstract][Full Text] [Related]
9. PTML Combinatorial Model of ChEMBL Compounds Assays for Multiple Types of Cancer.
Bediaga H; Arrasate S; González-Díaz H
ACS Comb Sci; 2018 Nov; 20(11):621-632. PubMed ID: 30240186
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the neuroprotective activity of rasagiline in cerebellar granule cells.
Bonneh-Barkay D; Ziv N; Finberg JP
Neuropharmacology; 2005 Mar; 48(3):406-16. PubMed ID: 15721173
[TBL] [Abstract][Full Text] [Related]
11. Perturbation Theory/Machine Learning Model of ChEMBL Data for Dopamine Targets: Docking, Synthesis, and Assay of New l-Prolyl-l-leucyl-glycinamide Peptidomimetics.
Ferreira da Costa J; Silva D; Caamaño O; Brea JM; Loza MI; Munteanu CR; Pazos A; García-Mera X; González-Díaz H
ACS Chem Neurosci; 2018 Nov; 9(11):2572-2587. PubMed ID: 29791132
[TBL] [Abstract][Full Text] [Related]
12. IFPTML Mapping of Drug Graphs with Protein and Chromosome Structural Networks vs. Pre-Clinical Assay Information for Discovery of Antimalarial Compounds.
Quevedo-Tumailli V; Ortega-Tenezaca B; González-Díaz H
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884870
[TBL] [Abstract][Full Text] [Related]
13. The essentiality of Bcl-2, PKC and proteasome-ubiquitin complex activations in the neuroprotective-antiapoptotic action of the anti-Parkinson drug, rasagiline.
Youdim MB; Amit T; Falach-Yogev M; Bar Am O; Maruyama W; Naoi M
Biochem Pharmacol; 2003 Oct; 66(8):1635-41. PubMed ID: 14555244
[TBL] [Abstract][Full Text] [Related]
14. MIND-BEST: Web server for drugs and target discovery; design, synthesis, and assay of MAO-B inhibitors and theoretical-experimental study of G3PDH protein from Trichomonas gallinae.
González-Díaz H; Prado-Prado F; García-Mera X; Alonso N; Abeijón P; Caamaño O; Yáñez M; Munteanu CR; Pazos A; Dea-Ayuela MA; Gómez-Muñoz MT; Garijo MM; Sansano J; Ubeira FM
J Proteome Res; 2011 Apr; 10(4):1698-718. PubMed ID: 21184613
[TBL] [Abstract][Full Text] [Related]
15. Mapping chemical structure-activity information of HAART-drug cocktails over complex networks of AIDS epidemiology and socioeconomic data of U.S. counties.
Herrera-Ibatá DM; Pazos A; Orbegozo-Medina RA; Romero-Durán FJ; González-Díaz H
Biosystems; 2015 Jun; 132-133():20-34. PubMed ID: 25916548
[TBL] [Abstract][Full Text] [Related]
16. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
Prado-Prado FJ; Martinez de la Vega O; Uriarte E; Ubeira FM; Chou KC; González-Díaz H
Bioorg Med Chem; 2009 Jan; 17(2):569-75. PubMed ID: 19112024
[TBL] [Abstract][Full Text] [Related]
17. Big Data Challenges Targeting Proteins in GPCR Signaling Pathways; Combining PTML-ChEMBL Models and [
Diez-Alarcia R; Yáñez-Pérez V; Muneta-Arrate I; Arrasate S; Lete E; Meana JJ; González-Díaz H
ACS Chem Neurosci; 2019 Nov; 10(11):4476-4491. PubMed ID: 31618004
[TBL] [Abstract][Full Text] [Related]
18. Entropy model for multiplex drug-target interaction endpoints of drug immunotoxicity.
Tenorio-Borroto E; García-Mera X; Peñuelas-Rivas CG; Vásquez-Chagoyán JC; Prado-Prado FJ; Castañedo N; González-Díaz H
Curr Top Med Chem; 2013; 13(14):1636-49. PubMed ID: 23889053
[TBL] [Abstract][Full Text] [Related]
19. N-alkylpiperidine carbamates as potential anti-Alzheimer's agents.
Košak U; Strašek N; Knez D; Jukič M; Žakelj S; Zahirović A; Pišlar A; Brazzolotto X; Nachon F; Kos J; Gobec S
Eur J Med Chem; 2020 Jul; 197():112282. PubMed ID: 32380361
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326 [(N-propargyl-(3R)aminoindan-5-YL)-ethyl methyl carbamate].
Youdim MB; Weinstock M
Cell Mol Neurobiol; 2001 Dec; 21(6):555-73. PubMed ID: 12043833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
